Patent ductus arteriosus screening
|
Patent Ductus Arteriosus Microchapters |
|
Differentiating Patent Ductus Arteriosus from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Patent ductus arteriosus screening On the Web |
|
American Roentgen Ray Society Images of Patent ductus arteriosus screening |
|
Risk calculators and risk factors for Patent ductus arteriosus screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
There is no routine screening guideline for patent ductus arteriosus screening, but if it diagnosed early, it can benefit preterm neonates.
Screening
- Patent ductus arteriosus is often diagnosed pre-partum by ultrasonography.[1]
- It can benefit extremely premature neonates by reducing short term mortality of those.[2]
- Checking for PDA is not a routine screening and is often times a randome finding.[3]
References
- ↑ Hamrick, S. E. G.; Hansmann, G. (2010). "Patent Ductus Arteriosus of the Preterm Infant". PEDIATRICS. 125 (5): 1020–1030. doi:10.1542/peds.2009-3506. ISSN 0031-4005.
- ↑ Clyman, Ronald I. (2000). "Ibuprofen and Patent Ductus Arteriosus". New England Journal of Medicine. 343 (10): 728–730. doi:10.1056/NEJM200009073431009. ISSN 0028-4793.
- ↑ Sosenko, Ilene R.S.; Fajardo, M. Florencia; Claure, Nelson; Bancalari, Eduardo (2012). "Timing of Patent Ductus Arteriosus Treatment and Respiratory Outcome in Premature Infants: A Double-Blind Randomized Controlled Trial". The Journal of Pediatrics. 160 (6): 929–935.e1. doi:10.1016/j.jpeds.2011.12.031. ISSN 0022-3476.